Mitochondrial DNA analysis by multiplex denaturing high-performance liquid chromatography and selective sequencing in pediatric patients with cardiomyopathy

Genetics in Medicine

Volumn 11, Issue 2, 2009, Pages 118-126

  Schrijver, Iris ^a   Pique, Lynn M ^a   Traynis, Ilana ^a   Scharfe, Curt ^a   Sehnert, Amy J ^b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiomyopathy; DHPLC; Diagnostics; LHON; Mitochondrial; mtDNA; NADH; Sequencing

Indexed keywords

MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ADOLESCENT; ARTICLE; CARDIOMYOPATHY; CHILD; CHILD CARE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DIZYGOTIC TWINS; DNA DETERMINATION; DNA SEQUENCE; FEMALE; GENE MUTATION; HETEROPLASMY; HOMOPLASY; HUMAN; IDIOPATHIC DISEASE; INFANT; LEBER HEREDITARY OPTIC NEUROPATHY; MALE; MITOCHONDRIAL GENOME; SEQUENCE ANALYSIS;

ADOLESCENT; ADULT; CARDIOMYOPATHIES; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE;

EID: 62149127790     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e318190356b     Document Type: Article

References (32)

1. Sehnert AJ. Use of denaturing high-performance liquid chromatography to detect mutations in pediatric cardiomyopathies. Methods Mol Med 2006;126:257-270.
2. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003;348:1647-1655.
3. Nugent AW, Daubeney PE, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003;348:1639-1646.
4. Blair E, Redwood C, de Jesus Oliveira M, et al. Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy. Circ Res 2002;90:263-269.
5. Ackerman MJ, VanDriest SL, Ommen SR, et al. Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. J Am Coll Cardiol 2002;39:2042-2048.
6. Van Driest SL, Ackerman MJ, Ommen SR, et al. Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy. Circulation 2002;106:3085-3090.
7. Van Driest SL, Jaeger MA, Ommen SR, et al. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;44:602-610.
8. Van Driest SL, Ellsworth EG, Ommen SR, et al. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation 2003;108:445-451.
9. Mogensen J, Bahl A, Kubo T, Elanko N, Taylor R, McKenna WJ. Comparison of fluorescent SSCP and denaturing HPLC analysis with direct sequencing for mutation screening in hypertrophic cardiomyopathy. J Med Genet 2003;40:e59.
10. Monta H, Larson MG, Barr SC, et al. Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study. Circulation 2006;113:2697-2705.
11. Oliveira SM, Ehtisham J, Redwood CS, Ostman-Smith I, Blair EM, Watkins H. Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis. J Mol Cell Cardiol 2003;35:1251-1255.
12. Vaughan CJ, Hom Y, Okin DA, McDermott DA, Lerman BB, Basson CT. Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol 2003;14:263-268.
13. Lev D, Nissenkorn A, Leshinsky-Silver E, et al. Clinical presentations of mitochondrial cardiomyopathies. Pediatr Cardiol 2004;25:443-450.
14. Holmgren D, Wåhlander H, Eriksson BO, Oldfors A, Holme E, Tulinius M. Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings. Eur Heart J 2003;24:280-288.
15. Scaglia F, Towbin JA, Craigen WJ, et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 2004;114:925-931.
16. Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ, Filiano JJ, Perez-Atayde A. Mitochondrial dysfunction in skeletal muscle of children with cardiomyopathy. Pediatrics 1999;103:456-459.
17. Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ, Pierpont ME. Biochemical and molecular basis for mitochondrial cardiomyopathy in neonates and children. J Inherit Metab Dis 2000;23:625-633.
18. Guenthard J, Wyler F, Fowler B, Baumgartner R. Cardiomyopathy in respiratory chain disorders. Arch Dis Child 1995;72:223-226.
19. van Den Bosch BJ, de Coo RF, Scholte HR, et al. Mutation analysis of the entire mitochondrial genome using denaturing high performance liquid chromatography. Nucleic Acids Res 2000;28:E89.
20. Conley YP, Brockway H, Beatty M, Kerr ME. Qualitative and quantitative detection of mitochondrial heteroplasmy in cerebrospinal fluid using denaturing high-performance liquid chromatography. Brain Res Brain Res Protoc 2003;12:99-103.
21. Bayat A, Walter J, Lamb H, Marino M, Ferguson MW, Oilier WE. Mitochondrial mutation detection using enhanced multiplex denaturing high-performance liquid chromatography. Int J Immunogenet 2005;32:199-205.
22. Liu MR, Pan KF, Li ZF, et al. Rapid screening mitochondrial DNA mutation by using denaturing high-performance liquid chromatography. World J Gastroenterol 2002;8:426-430.
23. Biggin A, Henke R, Bennetts B, et al. Mutation screening of the mitochondrial genome using denaturing high-performance liquid chromatography. Mol Genet Metab 2005;84:61-74.
24. Wulfert M, Tapprich C, Gattermann N. Optimized PCR fragments for heteroduplex analysis of the whole human mitochondrial genome with denaturing HPLC. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 831:236-247.
25. Lim KS, Naviaux RK, Haas RH. Quantitative mitochondrial DNA mutation analysis by denaturing HPLC. Clin Chem 2007;53:1046-1052.
26. Lim KS, Naviaux RK, Wong S, Haas RH. Pitfalls in the denaturing high-performance liquid chromatography analysis of mitochondrial DNA mutation. J Mol Diagn 2008;10:102-108.
27. Nikoskelainen EK, Savontaus ML, Huoponen K, Antila K, Hartiala J. Pre-excitation syndrome in Leber's hereditary optic neuropathy. Lancet 1994;344:857-858.
28. Mashima Y, Kigasawa K, Hasegawa H, Tani M, Oguchi Y. High incidence of pre-excitation syndrome in Japanese families with Leber's hereditary optic neuropathy. Clin Genet 1996;50:535-537.
29. Dandekar SS, Graham EM, Plant GT. Ladies with Leber's hereditary optic neuropathy: an atypical disease. Eur J Ophthalmol 2002;12:537-541.
30. Fischel-Ghodsian N. Mitochondrial deafness. Ear Hear 2003;24:303-313.
31. Moraes CT, Atencio DP, Oca-Cossio J, Diaz F. Techniques and pitfalls in the detection of pathogenic mitochondrial DNA mutations. J Mol Diagn 2003;5:197-208.
32. Leonard JV, Schapira AH. Mitochondrial respiratory chain disorders. I. Mitochondrial DNA defects. Lancet 2000;355:299-304.